Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Updated Data on DFS, OS, and Safety in Pts Receiving Adj Atezo After Neoadj Atezo Jul 31, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Tumor Growth Inhibition-OS Model: Alectinib Data Validation Jul 27, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Atezolizumab Monotherapy vs Single-Agent Chemotherapy in Platinum-Ineligible NSCLC Patients Jul 19, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),Other Cancers Entrectinib Demonstrates Safety and Effectiveness in Metastatic ROS1 Fusion-Positive Lung Cancer Jun 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) KEYNOTE-010 Study: Pembrolizumab Shows Long-Term Survival Benefit in Advanced NSCLC Jun 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Durvalumab Treatment and Real-World Survival in Stage III NSCLC: PACIFIC-R Trial Jun 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Evaluate PK, Efficacy, Safety of HER3-DXd in EGFRm NSCLC: Study 1190TiP Jun 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) ctDNA Levels and Response to TIS + Chemo in Advanced NSCLC Jun 30, 2023
